165 related articles for article (PubMed ID: 32852057)
41. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
42. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
Liu RM; Xu P; Chen Q; Feng SL; Xie Y
Phytomedicine; 2020 Dec; 79():153342. PubMed ID: 32992085
[TBL] [Abstract][Full Text] [Related]
43. Purine analogs sensitize the multidrug resistant cell line (NCI-H460/R) to doxorubicin and stimulate the cell growth inhibitory effect of verapamil.
Pesić M; Podolski A; Rakić L; Ruzdijić S
Invest New Drugs; 2010 Aug; 28(4):482-92. PubMed ID: 19533022
[TBL] [Abstract][Full Text] [Related]
44. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
Yuan F; Liu J; Qiao T; Li T; Shen Q; Peng F
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367657
[TBL] [Abstract][Full Text] [Related]
45. [Experimental study on thermochemotherapy combined with verapamil for reversing the multidrug resistance responsible to breast cancer cell].
Yan X; Hou M; Li SF; Liu YY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):391-3. PubMed ID: 18575322
[TBL] [Abstract][Full Text] [Related]
46. Synergistic effect of paclitaxel and verapamil to overcome multi-drug resistance in breast cancer cells.
Li P; Zhong D; Gong PY
Biochem Biophys Res Commun; 2019 Aug; 516(1):183-188. PubMed ID: 31204050
[TBL] [Abstract][Full Text] [Related]
47. Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance.
Wang B; Ma LY; Wang JQ; Lei ZN; Gupta P; Zhao YD; Li ZH; Liu Y; Zhang XH; Li YN; Zhao B; Chen ZS; Liu HM
J Med Chem; 2018 Jul; 61(14):5988-6001. PubMed ID: 29975529
[TBL] [Abstract][Full Text] [Related]
48. Key structure of brij for overcoming multidrug resistance in cancer.
Tang J; Wang Y; Wang D; Wang Y; Xu Z; Racette K; Liu F
Biomacromolecules; 2013 Feb; 14(2):424-30. PubMed ID: 23311629
[TBL] [Abstract][Full Text] [Related]
49. New Seco-DSP derivatives as potent chemosensitizers.
Wan Q; Jin X; Guo Y; Yu Z; Guo S; Morris-Natschke S; Lee KH; Liu H; Chen Y
Eur J Med Chem; 2020 Oct; 204():112555. PubMed ID: 32750634
[TBL] [Abstract][Full Text] [Related]
50. A new insight into the reversal of multidrug resistance in cancer by nanodrugs.
Jiang H; Guo D; Chen D; Wu Y; Jin X; Zhu X
Biomater Sci; 2019 Aug; 7(8):3489-3496. PubMed ID: 31282916
[TBL] [Abstract][Full Text] [Related]
51. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
52. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of the optical isomers of KR30031 on cardiotoxicity and on multidrug resistance reversal activity.
Lee BH; Lee CO; Kwon MJ; Yi KY; Yoo SE; Choi SU
Anticancer Drugs; 2003 Feb; 14(2):175-81. PubMed ID: 12569305
[TBL] [Abstract][Full Text] [Related]
54. Vitamin E reverses multidrug resistance in vitro and in vivo.
Tang J; Fu Q; Wang Y; Racette K; Wang D; Liu F
Cancer Lett; 2013 Aug; 336(1):149-57. PubMed ID: 23624302
[TBL] [Abstract][Full Text] [Related]
55. A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives.
Min KH; Xia Y; Kim EK; Jin Y; Kaur N; Kim ES; Kim DK; Jung HY; Choi Y; Park MK; Min YK; Lee K; Lee K
Bioorg Med Chem Lett; 2009 Sep; 19(18):5376-9. PubMed ID: 19679475
[TBL] [Abstract][Full Text] [Related]
56. Mechanism of Induction of P-gp Activity During MET Induced by DEX in Lung Cancer Cell Line.
Liu W; Zhang X; Sunakawa H; Perera LMB; Martha L; Mizoi K; Ogihara T
J Pharm Sci; 2024 Jun; 113(6):1674-1681. PubMed ID: 38432625
[TBL] [Abstract][Full Text] [Related]
57. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
58. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy.
Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z
Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433
[TBL] [Abstract][Full Text] [Related]
59. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil.
Laberge RM; Ambadipudi R; Georges E
Arch Biochem Biophys; 2009 Nov; 491(1-2):53-60. PubMed ID: 19772851
[TBL] [Abstract][Full Text] [Related]
60. P-glycoprotein modulates oleanolic acid effects in hepatocytes cancer cells and zebrafish embryos.
Kayouka M; Hamade A; Saliba E; Najjar F; Landy D; Greige-Gerges H
Chem Biol Interact; 2020 Jan; 315():108892. PubMed ID: 31704064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
